Navigation Links
Patent Technologies Keep CGMT in a Leading Position in the Industry
Date:10/27/2008

w fully degradable material, with Mr. QIAO Yingjie, expert on composite material, professor and tutor of postgraduate candidates of Materials Science at Institute of Chemical Technology of Harbin Engineering University, as the leader of the research team.

Because of his outstanding achievement in the scientific research, QIAO Yingjie was elected as an Olympic Torchbearer.

At present, the R&D experts of CGMT are developing new technologies and new products in order to lay a solid foundation for greater achievements.

For more information, please contact:

Miss Meng

Tel: +86-451-8269-5957

Email: secretary@chfy.com.cn


'/>"/>
SOURCE China Green Material Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... market the TriPollar Technology- the most advanced 3rd generation Radio Frequency ... have been clinically proven the world over to be safe and ... non-invasive and patients enjoy visible results from the very 1st treatment. ... treatments. , ... Tel Aviv, Israel (PRWEB) ...
(Date:12/6/2009)... Conn., Dec. 6 Boehringer Ingelheim today ... etexilate (150 mg BID), a direct thrombin inhibitor ... acute VTE. Results of the trial were ... Annual Meeting and simultaneously published online in the ... ,, Dabigatran etexilate met the primary outcome of ...
(Date:12/4/2009)... Products (ACAMP) hosts, health & ... Today ACAMP hosted a health & medical seminar, ... can play a powerful role in the creation ... and improve the quality, cost and outcomes of ...
(Date:12/3/2009)... of Houston, LLC announced today that it has ... option, vertical sleeve gastrectomy , along with the ... first sleeve gastrectomy procedure at the facility was performed ... on October 20, 2009. The patient is reported as ...
Breaking Biology Technology:Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Alberta companies delivering new products to the health & medical marketplace 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2
... TeleHealth Services , the ... education, healthcare televisions and communications solutions, today announced a ... The facility opened Park Tower, a new wing of ... TeleHealth Services as its healthcare television provider. "When ...
... MINNEAPOLIS, April 28 Techne Corporation (Nasdaq: TECH ... pay a dividend of $0.25 per share for the quarter ... payable May 22, 2009 to all common shareholders of record ... considered by the Board of Directors on a quarterly basis.Techne,s ...
... healthy volunteer study of IMX942 will provide human safety ... - Inimex Pharmaceuticals is pleased to announce that its ... human subjects for the first time on April 27, ... 1 safety study of IMX942 being performed for Inimex ...
Other Biology Technology:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 2TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 3Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program 2Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator 2
(Date:12/3/2009)... Preliminary Press Conference Topics, Last Call! Press Field ... PIOs: Sending Press Releases to Fall meeting, NCSWA ... Media registration information , News Media Registration Form ... , For important information regarding visas for ...
(Date:12/3/2009)... N.M. Most scientists believe that staph infections are caused ... toxins. The signaling process is called quorum sensing because many ... the Jeff Brinker research group has determined that the very ... harmless to a virulent form, occurs in a single cell ...
(Date:12/3/2009)... reef fish can undergo a personality change in warmer water, ... may make some species more aggressive. , Experiments with two ... shown for the first time that some reef fish are ... differences are even more marked as water temperatures rise. , ...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Fish with attitude: Some like it hot 2Launch of First Year Round Annual Scientific Medical Meeting Announced at Health 2 0 59299 1Launch of First Year Round Annual Scientific Medical Meeting Announced at Health 2 0 59299 2California Walnuts Popular Smart Menus Program Getting Smarter 59297 1California Walnuts Popular Smart Menus Program Getting Smarter 59297 2California Walnuts Popular Smart Menus Program Getting Smarter 59297 3Regulatory Leader in OASIS Documentation Introduces OASIS C Products 5400 1Regulatory Leader in OASIS Documentation Introduces OASIS C Products 5400 2
... international research team believes that changes in behaviour among the ... Eastern Zimbabwe. , Research published today in Science shows how ... prevalence in some groups, which the researchers attribute to people ... partners. , They found HIV prevalence fell most steeply at ...
... the next generation of human therapeutic drugs. , A ... Queensland University of Technology PhD researcher Liam St Pierre ... major trauma. , The genetic code for the toxin, ... Liam St Pierre from QUT's School of Life Sciences ...
... work. Biology researchers at Lewis & Clark College and ... ancient transfer of a toxin between ancestors of two ... remains as how the toxin passed between the two ... journal Bioinformatics, 22(3): 264-268, in an article titled "Lateral ...
Other Biology News:HIV decline in Zimbabwe linked to behavioural change 2Taipan venom no snake oil 2Evolution mystery: Spider venom and bacteria share same toxin 2
Ready-to-use solution....
...
... Polyclonal Antibody Production Conjugated peptides ... ten-week protocol to produce antibodies in 2 ... ml antiserum) ELISA test until the titer ... reaches target titer Protein G purification ...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: